Epizam 0.5 mg (Tablet)
Unit Price: ৳ 5.00 (3 x 10: ৳ 150.00)
Strip Price: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Clonazepam |
Company | Alco pharma ltd |
Also available as |
Title
- Epizam 0.5 mg Tablet
Categories
- Medicine
- Pharmaceutical
Description
- Treatment of panic disorder with or without agoraphobia
- Adjunct treatment of Lennox-Gastaut Syndrome, petit mal variant, akinetic and myoclonic seizures
- Indicated in patients with absence seizures who have failed to respond to succinimides
- Mechanism of action mediated through enhancement of GABAergic neurotransmission
- Exhibits anticonvulsive, sedative, muscle relaxing, and anxiolytic effects
- Effect on serotonin and suppression of various types of paroxysmal activity
- Dosage range for adults with seizure disorders from 1.5 mg/day to maximum 20 mg/day
- Initial dose for adults with panic disorder is 0.25 mg given in two divided doses
- Dosage for pediatric patients based on body weight with specific limits
- Different dosage recommendations for oral and injectable forms
- No known alteration of pharmacokinetics of certain drugs by Epizam
- Contraindicated in patients with hypersensitivity to benzodiazepines
- Contraindicated in patients with significant liver disease and acute narrow angle glaucoma
- Frequent CNS depression-related side effects including drowsiness, ataxia, and behavior problems
- Potential risk and precautions associated with pregnancy and lactation
- Possible increased incidence of generalized tonic-clonic seizures in certain patient populations
- Special considerations for pediatric usage and geriatric patients
- Storage conditions requirement: dry place, away from light and heat
- Therapeutic class includes adjunct anti-epileptic drugs and benzodiazepine hypnotics
- Reconstitution guidelines for slow intravenous injection, intravenous infusion, and intramuscular injection
- Chemical structure with molecular formula C15H10ClN3O3
- Commonly asked questions covering usage, withdrawal symptoms, side effects, etc.